Cargando…

Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study

BACKGROUND: The incidence of coexisting myocardial ischemia and neurological symptoms in Takayasu arteritis (TA) is currently unknown. There is no standardized treatment algorithm in complex cases involving the coronary and intracranial arteries. OBJECTIVE: This study aimed to describe the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Junting, Wang, Bin, Yu, LiJun, Gao, Dewei, Cheng, Rui, Wang, Jiawei, Zhou, Xianliang, Tian, Tao, Gao, Linggen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385106/
https://www.ncbi.nlm.nih.gov/pubmed/35990973
http://dx.doi.org/10.3389/fcvm.2022.948124
_version_ 1784769526767812608
author Huo, Junting
Wang, Bin
Yu, LiJun
Gao, Dewei
Cheng, Rui
Wang, Jiawei
Zhou, Xianliang
Tian, Tao
Gao, Linggen
author_facet Huo, Junting
Wang, Bin
Yu, LiJun
Gao, Dewei
Cheng, Rui
Wang, Jiawei
Zhou, Xianliang
Tian, Tao
Gao, Linggen
author_sort Huo, Junting
collection PubMed
description BACKGROUND: The incidence of coexisting myocardial ischemia and neurological symptoms in Takayasu arteritis (TA) is currently unknown. There is no standardized treatment algorithm in complex cases involving the coronary and intracranial arteries. OBJECTIVE: This study aimed to describe the clinical characteristics and outcomes in patients with TA coexisting with myocardial ischemia and neurological symptoms. METHODS: We retrospectively collected and assessed 1,580 patients with TA, and enrolled patients with myocardial ischemia and neurological symptoms from January 2002 to December 2021 in several hospitals. The incidence, clinical features, management strategy, and prognosis of these patients were evaluated. RESULTS: Ninety-four (5.9%, 94/1,580) patients with TA coexisting with myocardial ischemia and neurological symptoms were included in the present study. Imaging results showed that the subclavian arteries were the most frequently affected arteries and 37 patients had intracranial vascular abnormalities, comprising the basilar artery (6.1%, 17/279), middle cerebral artery (2.5%, 7/279), anterior cerebral artery (2.9%, 8/279), and posterior cerebral artery (1.9%, 5/279). Among patients with neurological symptoms, 25 patients underwent percutaneous transluminal angioplasty and 20 patients underwent stent implantation. The most common site of stenosis was the ostial and proximal segments of the coronary artery, with 142 lesions among 188 (75.5%) lesions. Thirty-eight patients adopted interventional therapy, 21 patients underwent surgical treatment, and the remaining 35 patients received conservative treatment. There were 20 (21.27%, 20/94) late deaths during a mean follow-up of 57.79 months. The mortality rate in the conservative treatment group was significantly higher than that in the interventional therapy and surgical treatment groups. CONCLUSION: Patients with TA involving both the coronary and intracranial vessels are not rare. Stenosis and occlusion lesions most frequently involve the ostia and proximal segment of the arteries. Severe vascular lesions should be revascularized as soon as possible. These patients should be supplemented with glucocorticoids, antiplatelet, nitrates, and statins.
format Online
Article
Text
id pubmed-9385106
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93851062022-08-18 Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study Huo, Junting Wang, Bin Yu, LiJun Gao, Dewei Cheng, Rui Wang, Jiawei Zhou, Xianliang Tian, Tao Gao, Linggen Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: The incidence of coexisting myocardial ischemia and neurological symptoms in Takayasu arteritis (TA) is currently unknown. There is no standardized treatment algorithm in complex cases involving the coronary and intracranial arteries. OBJECTIVE: This study aimed to describe the clinical characteristics and outcomes in patients with TA coexisting with myocardial ischemia and neurological symptoms. METHODS: We retrospectively collected and assessed 1,580 patients with TA, and enrolled patients with myocardial ischemia and neurological symptoms from January 2002 to December 2021 in several hospitals. The incidence, clinical features, management strategy, and prognosis of these patients were evaluated. RESULTS: Ninety-four (5.9%, 94/1,580) patients with TA coexisting with myocardial ischemia and neurological symptoms were included in the present study. Imaging results showed that the subclavian arteries were the most frequently affected arteries and 37 patients had intracranial vascular abnormalities, comprising the basilar artery (6.1%, 17/279), middle cerebral artery (2.5%, 7/279), anterior cerebral artery (2.9%, 8/279), and posterior cerebral artery (1.9%, 5/279). Among patients with neurological symptoms, 25 patients underwent percutaneous transluminal angioplasty and 20 patients underwent stent implantation. The most common site of stenosis was the ostial and proximal segments of the coronary artery, with 142 lesions among 188 (75.5%) lesions. Thirty-eight patients adopted interventional therapy, 21 patients underwent surgical treatment, and the remaining 35 patients received conservative treatment. There were 20 (21.27%, 20/94) late deaths during a mean follow-up of 57.79 months. The mortality rate in the conservative treatment group was significantly higher than that in the interventional therapy and surgical treatment groups. CONCLUSION: Patients with TA involving both the coronary and intracranial vessels are not rare. Stenosis and occlusion lesions most frequently involve the ostia and proximal segment of the arteries. Severe vascular lesions should be revascularized as soon as possible. These patients should be supplemented with glucocorticoids, antiplatelet, nitrates, and statins. Frontiers Media S.A. 2022-08-03 /pmc/articles/PMC9385106/ /pubmed/35990973 http://dx.doi.org/10.3389/fcvm.2022.948124 Text en Copyright © 2022 Huo, Wang, Yu, Gao, Cheng, Wang, Zhou, Tian and Gao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Huo, Junting
Wang, Bin
Yu, LiJun
Gao, Dewei
Cheng, Rui
Wang, Jiawei
Zhou, Xianliang
Tian, Tao
Gao, Linggen
Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study
title Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study
title_full Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study
title_fullStr Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study
title_full_unstemmed Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study
title_short Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study
title_sort clinical characteristics and outcomes in patients with takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: a multicenter, long-term, follow-up study
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385106/
https://www.ncbi.nlm.nih.gov/pubmed/35990973
http://dx.doi.org/10.3389/fcvm.2022.948124
work_keys_str_mv AT huojunting clinicalcharacteristicsandoutcomesinpatientswithtakayasuarteritiscoexistingwithmyocardialischemiaandneurologicalsymptomsamulticenterlongtermfollowupstudy
AT wangbin clinicalcharacteristicsandoutcomesinpatientswithtakayasuarteritiscoexistingwithmyocardialischemiaandneurologicalsymptomsamulticenterlongtermfollowupstudy
AT yulijun clinicalcharacteristicsandoutcomesinpatientswithtakayasuarteritiscoexistingwithmyocardialischemiaandneurologicalsymptomsamulticenterlongtermfollowupstudy
AT gaodewei clinicalcharacteristicsandoutcomesinpatientswithtakayasuarteritiscoexistingwithmyocardialischemiaandneurologicalsymptomsamulticenterlongtermfollowupstudy
AT chengrui clinicalcharacteristicsandoutcomesinpatientswithtakayasuarteritiscoexistingwithmyocardialischemiaandneurologicalsymptomsamulticenterlongtermfollowupstudy
AT wangjiawei clinicalcharacteristicsandoutcomesinpatientswithtakayasuarteritiscoexistingwithmyocardialischemiaandneurologicalsymptomsamulticenterlongtermfollowupstudy
AT zhouxianliang clinicalcharacteristicsandoutcomesinpatientswithtakayasuarteritiscoexistingwithmyocardialischemiaandneurologicalsymptomsamulticenterlongtermfollowupstudy
AT tiantao clinicalcharacteristicsandoutcomesinpatientswithtakayasuarteritiscoexistingwithmyocardialischemiaandneurologicalsymptomsamulticenterlongtermfollowupstudy
AT gaolinggen clinicalcharacteristicsandoutcomesinpatientswithtakayasuarteritiscoexistingwithmyocardialischemiaandneurologicalsymptomsamulticenterlongtermfollowupstudy